Navigation Links
AMP president updates CDC committee on H1N1 testing
Date:9/2/2009

Atlanta, GASeptember 2-3, 2009 Dr. Jan Nowak, President of the Association for Molecular Pathology presented public comments today at the Clinical Laboratory Improvement Advisory Committee meeting. During the initial weeks of the pandemic H1N1 influenza outbreak, community based molecular pathology laboratories developed diagnostic tests capable of rapidly detecting and confirming suspected cases of pandemic flu. Dr. Nowak reported on the efforts to confirm suspected cases in the Chicago area and among the broader AMP membership and discussed the challenges encountered by the diagnostic community as well as the opportunities to improve access to high quality rapid diagnostic tests for pandemic influenza.

AMP members stand ready to help with surge capacity during a reemergence of pandemic influenza strain during this year's flu season. Last April, when the first reports of the novel H1N1 influenza strain began to appear, community molecular pathology laboratories were confronted with the task of providing timely, useful information to their clinicians about this new infectious agent. An informal survey of AMP member laboratories during the first week of the H1N1 episode showed that 93% of the 43 respondents had a molecular assay that could detect and distinguish Influenza Type A from Type B. Those laboratories had an aggregate test capacity of 3,000 to 4,000 specimens/day, and could expand their capacity to as much as 12,000 specimens/day within 30 days if needed. Thirty-six percent of the laboratories reported having the capability of distinguishing the novel H1N1 strain from seasonal H1 strains. During week one of the outbreak, those laboratories had an aggregate test capacity approaching 2,500 specimens/day, with a potential of nearly 8,000 specimens/day within 30 days.

AMP members are uniquely qualified to develop and validate rapid diagnostics to confirm clinical cases of pandemic flu.

Early in week one of the outbreak, the molecular laboratories in the Chicago area participated in a conference call with the Illinois Department of Public Health to exchange information about tests in use, testing capacity, confirmatory capabilities, etc. Within a week the community labs had sufficient information to know that available assays for influenza A were capable of detecting the novel H1N1 strain, and furthermore, that some assays were capable of specifically identifying the novel H1N1 subtype. This knowledge greatly reduced the number of specimens that needed to be confirmed by IDPH. By the end of week two of the outbreak, many labs had sufficient data from IDPH to validate their assays, and were asked to limit their submissions for IDPH confirmation. After four weeks, more cases of H1N1 had been diagnosed in community molecular diagnostic laboratories (790 cases) than by IDPH (698 cases).

Dr. Nowak shared his experience, "by the end of the first week of the H1N1 episode, our own laboratory had identified 39 cases of probable H1N1 infection, only a fraction of which had been corroborated by our state public health laboratory, and confirmed only sometime after day 8." The CDC tally for all of Illinois at the end that week was still only 3 cases confirmed, a number widely reported in the media, which greatly misinformed the public and the medical community of the true nature of the spread of this disease in Illinois.

With the President's Council of Advisors on Science and Technology warning that more than half of the US population will be infected with the H1N1 influenza virus this flu season, AMP encourages close collaboration between molecular diagnostics laboratories, CDC, and public health laboratories to ensure prompt diagnosis and timely surveillance of the outbreak. Dr. Nowak expressed his pride in his profession's role in the outbreak, "In the recent H1N1 outbreak, I believe the quality of laboratory testing has been outstanding, as has been the response of molecular diagnostics laboratories to this public health emergency."


'/>"/>

Contact: Mary Steele Williams
mwilliams@amp.org
301-634-7921
Association for Molecular Pathology
Source:Eurekalert

Related biology news :

1. Presidents of Iceland, Bangladesh to discuss global climate change in New Orleans
2. Beginning scientists receive presidential awards
3. President honors mentors of scientists and engineers
4. IEEE-USA commends president for asking Congress to double support for critical research
5. Presidents science adviser to address IEEE International Homeland Security Conference
6. New book tutors future presidents and public on science behind the headlines
7. The Science Coalitions 10 questions for the presidential debate
8. Haag honored with Presidential Early Career Scientists Award
9. Small changes can lead to big rewards, says ASN president
10. Press statement on new CDC MRSA study from SHEA president
11. Innerscope Research(R) Appoints Digital Leader, Andre Marquis, as Senior Vice President of Sales and Marketing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/3/2017)... 2017 Onitor, provider of digital health technology ... an innovative biometric data-driven program designed to aid weight ... the 2017 Consumer Electronics Show (CES) in ... U.S., the World Health Organization (WHO), have identified lifestyle ... who are overweight or obese. WHO also states that ...
(Date:12/19/2016)... España y TORONTO , 19 de diciembre de ... Biologics Inc. que permitirá el desarrollo acelerado de MSC-1, un anticuerpo ... varios tipos de tumor en 2017, con múltiples sitios previstos a ... ... con objetivo en el factor inhibidor de leucemia (LIF), una citoquina ...
(Date:12/15/2016)... , Dec. 15, 2016   WaferGen Bio-systems, Inc. ... genomics technology company, announced today that on December 13, ... Department of The Nasdaq Stock Market LLC which acknowledged ... price of WaferGen,s common stock had been at $1.00 ... has regained compliance with Listing Rule 5550(a)(2) of the ...
Breaking Biology News(10 mins):
(Date:1/24/2017)... GA (PRWEB) , ... January 24, 2017 , ... ... and instrument solutions, announces the appointment of Steven F. McAllister as Executive Vice ... device experience in both the U.S. and international markets. Beginning his career at ...
(Date:1/24/2017)... ... January 24, 2017 , ... ... upgrade its Nor-Tech cluster with user-friendly bootable Intel KNL. , Currently Cal ... integrated into Nor-Tech’s demo cluster. The demo cluster is a no-cost, no-strings opportunity ...
(Date:1/24/2017)... ... ... Oklahoma City based Sigma Blood Systems has established a relationship with Central ... product QC Manager 2.0. , Sigma Blood Systems CEO, Max Doleh, stated “We ... have decided to implement PERFEQTA and QC Manager 2.0, with PERFEQTA launching across multiple ...
(Date:1/24/2017)... YORK , Jan. 23, 2017  Today, the ... announce they have funded an important study that could ... prevent the onset of Alzheimer,s disease. This groundbreaking research ... Rockefeller University, led by Nobel Laureate Dr. Paul ... for Alzheimer,s disease. Fisher Center scientists have ...
Breaking Biology Technology: